XML 24 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
STATEMENTS OF CASH FLOWS (USD $)
In Thousands
6 Months Ended 95 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Cash flows from operating activities:      
Net loss $ (49,732) $ (8,614) $ (173,546)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 95 116 1,744
Stock-based compensation 1,314 2,174 13,855
Change in fair value of warrants 8,965 (1,049) 11,827
Common stock issued in exchange for in-process research and development 17,457   17,457
Loss on disposal of fixed assets     9
(Increase) decrease in:      
Prepaid expenses and other current assets (592) 76 (1,016)
Other noncurrent assets (519) 30 (883)
Deposits (4) (41) (91)
Increase (decrease) in:      
Accounts payable 753 (646) 1,784
Accrued expenses 3,546 (122) 6,084
Deferred revenue 4,733   4,733
Deferred rent (5) (28) 81
Net cash used in operating activities (13,989) (8,104) (117,962)
Cash flows from investing activities:      
Purchases of property and equipment (392) (78) (2,303)
Proceeds from sale of property and equipment     1
Net cash used in investing activities (392) (78) (2,302)
Cash flows from financing activities:      
Stockholders' capital contribution     500
Proceeds from exercise of stock options 849 176 1,212
Payments to employees for repurchase of common stock (78) (47) (2,126)
Proceeds from exercise of warrants 12,293 72 12,644
Proceeds from issuance of common stock and warrants, net 71,207 32,804 221,556
Proceeds from issuance of preferred stock, net     16,760
Net cash provided by financing activities 84,271 33,005 250,546
Net increase (decrease) in cash and cash equivalents 69,890 24,823 130,282
Cash and cash equivalents, beginning of period 60,392 48,839  
Cash and cash equivalents, end of period 130,282 73,662 130,282
Supplementary disclosure of cash flow information:      
Cash paid for interest      
Cash paid for income taxes      
Supplementary disclosure of noncash investing and financing activities:      
Warrants issued to placement agents and investors     47,276
Exercise of liability-classified warrants to common shares 265 49 314
Convertible Preferred Stock
     
Supplementary disclosure of noncash investing and financing activities:      
Preferred stock conversion/exercise of equity-classified warrants to common stock     16,760
Warrant
     
Supplementary disclosure of noncash investing and financing activities:      
Preferred stock conversion/exercise of equity-classified warrants to common stock $ 8,992 $ 239 $ 9,249